From Ideas to Impact: Emerging Health Technologies in Action

1 – 2 Jun 2026 | Brussels, Belgium

Project cooperationUpdated on 14 May 2026

AIBA - Artificial Intelligence and Bio-Medical Applications

EITs Master contact at University of Barcelona

Barcelona, Spain

About

The Artificial Intelligence and Bio-Medical Applications (AIBA) consolidated research group, specializing in Artificial Intelligence (AI) technologies (Machine Learning, Deep Learning, Computer Vision, Data Science,  Medical Imaging, etc.,) is actively seeking collaboration opportunities. We are looking for project proposals where we can contribute our technological expertise and work together by innovative AI solutions. The group has long experience in participating and coordinating in HorizonEurope, Horizon2020, EIT Health, EIT Digital, and other EU frameworks.

Contact: petia.ivanova@ub.edu

Similar opportunities

  • Expertise

    Health economic

    Montse Cruz Gatell

    EITs Master contact at University of Barcelona

    Barcelona, Spain

  • Project cooperation

    CortexView Imaging Intelligence™ – AI-Enhanced Acquisition and Diagnosis

    • IHI Topic 1: IHI European healthcare incubator network
    • Partner offering expertise and is looking for a consortium
    • IHI Topic 3: Decode the immuno-science of age-related mediated diseases
    • HORIZON-MISS-2026-02-CANCER-04: Earlier and more precise palliative care (RIA)
    • HORIZON-MISS-2026-02-CANCER-01: Virtual Human Twin (VHT) Models for Cancer Research (RIA)
    • HORIZON-MISS-2026-02-CANCER-07: Improve the Quality of Life of older cancer patients (RIA)
    • HORIZON-MISS-2026-02-CANCER-02: Microbiome for early cancer prediction before the onset of disease (RIA)
    • HORIZON_MISS-2027-02-CANCER-01 Leveraging functional genomics to reveal novel targets for cancer treatment
    • IHI Topic 2: An AI foundation toxicology model and framework to support waiving a second species in drug safety studies
    • HORIZON-MISS-2026-02-CANCER-06: Development of a research capacity building programme on cancer with and for Ukraine (RIA)
    • HORIZON_MISS-2027-02-CANCER-02 Clinical research by Comprehensive Cancer Infrastructures for the benefit of patients with common cancers
    • HORIZON-MISS-2026-02-CANCER-03: Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers (RIA)
    • HORIZON-MISS-2026-02-CANCER-05: Boosting mental health of young cancer survivors through the European Cancer Patient Digital Centre (ECPDC) (IA)
    • HORIZON_MISS-2027-02-CANCER-06 Support a Young Cancer Survivor Quality of Life (QoL) research programme by cancer charities and funding agencies
    • HORIZON_MISS-2027-02-CANCER-05 Pre-commercial procurement of affordable solutions for healthcare systems in the areas of cancer technologies, cancer medical devices, or cancer medicines
    • HORIZON_MISS-2027-02-CANCER-04 Improving equitable health outcomes and added value for and with cancer patients through health-economics research, health systems research and outcomes research
    • HORIZON_MISS-2027-02-CANCER-03 Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes

    Miadreza Shafiekhah

    Head of Research and Innovation at Nowocert

    Dublin, Ireland

  • Expertise

    Expertise on biotech and deeptech problems

    Christos Kotakis

    CEO, Founder at citrusgenetics

    Gastouni, Greece